Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 506

1.

Genome size and lifestyle in gnesiotrochan rotifers.

Brown PD, Walsh EJ.

Hydrobiologia. 2019 Nov;844(1):105-115. doi: 10.1007/s10750-018-3873-8. Epub 2019 Jan 3.

PMID:
31798186
2.
3.

Optimizing whole brain radiotherapy dose and fractionation: Results from a prospective phase III trial (NCCTG N107C (Alliance)/CEC.3).

Trifiletti DM, Ballman KV, Brown PD, Anderson SK, Carrero XW, Cerhan JH, Whitton AC, Greenspoon J, Parney IF, Laack NN, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D.

Int J Radiat Oncol Biol Phys. 2019 Oct 22. pii: S0360-3016(19)33906-9. doi: 10.1016/j.ijrobp.2019.10.024. [Epub ahead of print]

PMID:
31654784
4.

Nodular Leptomeningeal Disease - A Distinct Pattern of Recurrence After Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability.

Turner BE, Prabhu RS, Burri SH, Brown PD, Pollom EL, Milano MT, Weiss SE, Iv M, Fischbein N, Soliman H, Lo SS, Chao ST, Cox BW, Murphy JD, Li G, Gephart MH, Nagpal S, Atalar B, Azoulay M, Thomas R, Tillman G, Durkee BY, Shah JL, Soltys SG.

Int J Radiat Oncol Biol Phys. 2019 Oct 9. pii: S0360-3016(19)33867-2. doi: 10.1016/j.ijrobp.2019.10.002. [Epub ahead of print]

PMID:
31605786
5.

Leptomeningeal disease following local brain irradiation: A new frontier.

Trifiletti DM, Brown PD.

Neuro Oncol. 2019 Oct 5. pii: noz187. doi: 10.1093/neuonc/noz187. [Epub ahead of print] No abstract available.

PMID:
31586201
6.

Management of low-grade glioma: a systematic review and meta-analysis.

Brown TJ, Bota DA, van Den Bent MJ, Brown PD, Maher E, Aregawi D, Liau LM, Buckner JC, Weller M, Berger MS, Glantz M.

Neurooncol Pract. 2019 Jul;6(4):249-258. doi: 10.1093/nop/npy034. Epub 2018 Aug 18. Review.

PMID:
31386075
7.

The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapy.

Laack NN, Pugh SL, Brown PD, Fox S, Wefel JS, Meyers C, Choucair A, Khuntia D, Suh JH, Roberge D, Wendland MM, Bruner D.

Neurooncol Pract. 2019 Jul;6(4):274-282. doi: 10.1093/nop/npy038. Epub 2018 Dec 3.

PMID:
31386073
8.

Examiner accuracy in cognitive testing in multisite brain-tumor clinical trials: an analysis from the Alliance for Clinical Trials in Oncology.

Cerhan JH, Anderson SK, Butts AM, Porter AB, Jaeckle K, Galanis E, Brown PD.

Neurooncol Pract. 2019 Jul;6(4):283-288. doi: 10.1093/nop/npy048. Epub 2018 Nov 24.

PMID:
31386061
9.

Biological subtypes and survival outcomes in breast cancer patients with brain metastases in the targeted therapy era.

Bastos DCA, Maldaun MVC, Sawaya R, Suki D, Lang FF, Brown PD, Rao G, Weinberg JS, Prabhu SS.

Neurooncol Pract. 2018 Aug;5(3):161-169. doi: 10.1093/nop/npx033. Epub 2017 Dec 23.

10.

Preliminary exploration of a computerized cognitive battery and comparison with traditional testing in patients with high-grade glioma.

Cerhan JH, Caine C, Anderson SK, Johnson DR, Lachance DH, Yan E, Brown PD.

Neurooncol Pract. 2019 Jan;6(1):71-77. doi: 10.1093/nop/npy013. Epub 2018 May 21.

PMID:
31386012
11.

Spine Stereotactic Radiosurgery for Metastatic Pheochromocytoma.

Mesko S, Deegan BJ, D'Souza NM, Ghia AJ, Chapman BV, Amini B, McAleer MF, Wang XA, Brown PD, Tatsui CE, Rhines L, Li J.

Cureus. 2019 May 23;11(5):e4742. doi: 10.7759/cureus.4742.

12.

Blood Pressure Screening Campaign in Jamaica: May Measurement Month 2017.

Nwokocha M, Romero CA, Holder C, Whylie N, Wong H, Lietch J, Wilks R, Hosang M, Francis S, Brown PD, Paul T, Abel W, Barton E, Wilks R, Nwokocha CR.

Am J Hypertens. 2019 Nov 15;32(12):1186-1191. doi: 10.1093/ajh/hpz117.

PMID:
31350551
13.

Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA).

Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu JB, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, Cameron B, Attia A, Molitoris J, Wu CC, Wang TJC, Lockney NA, Beal K, Parkhurst J, Buatti JM, Shanley R, Lou E, Tandberg DD, Kirkpatrick JP, Shi D, Shih HA, Chuong M, Saito H, Aoyama H, Masucci L, Roberge D, Mehta MP.

Clin Transl Radiat Oncol. 2019 Jun 27;18:39-45. doi: 10.1016/j.ctro.2019.06.007. eCollection 2019 Sep.

14.

Low incidence of late failure and toxicity after spine stereotactic radiosurgery: Secondary analysis of phase I/II trials with long-term follow-up.

Ning MS, Deegan BJ, Ho JC, Chapman BV, Bishop AJ, Allen PK, Tannir NM, Amini B, Briere TM, Wang XA, Tatsui CE, Rhines LD, Brown PD, Li J, Ghia AJ.

Radiother Oncol. 2019 Sep;138:80-85. doi: 10.1016/j.radonc.2019.06.003. Epub 2019 Jun 25.

PMID:
31252298
15.

Progress Toward Long-Term Survivors of Glioblastoma.

Cantrell JN, Waddle MR, Rotman M, Peterson JL, Ruiz-Garcia H, Heckman MG, Quiñones-Hinojosa A, Rosenfeld SS, Brown PD, Trifiletti DM.

Mayo Clin Proc. 2019 Jul;94(7):1278-1286. doi: 10.1016/j.mayocp.2018.11.031. Epub 2019 Jun 20.

PMID:
31230743
16.

Measuring the impact of a mandatory province-wide vaccinate-or-mask policy on healthcare worker absenteeism in British Columbia, Canada.

Murti M, Otterstatter M, Orth A, Balshaw R, Halani K, Brown PD, Hejazi S, Thompson D, Allison S, Bharmal A, Dawar M, Hoyano D, Lee V, Naus M, Pollock S, Bevanda J, Coughlin S, Fitzgerald J, Keen D, Maracle M, Sprague S, Henry B.

Vaccine. 2019 Jul 9;37(30):4008-4014. doi: 10.1016/j.vaccine.2019.06.007. Epub 2019 Jun 14.

17.

Measuring the impact of influenza vaccination on healthcare worker absenteeism in the context of a province-wide mandatory vaccinate-or-mask policy.

Murti M, Otterstatter M, Orth A, Balshaw R, Halani K, Brown PD, Hejazi S, Thompson D, Allison S, Bharmal A, Dawar M, Hoyano D, Lee V, Naus M, Pollock S, Bevanda J, Coughlin S, Fitzgerald J, Keen D, Maracle M, Sprague S, Henry B.

Vaccine. 2019 Jul 9;37(30):4001-4007. doi: 10.1016/j.vaccine.2019.06.014. Epub 2019 Jun 14.

18.

Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).

Jaeckle KA, Anderson SK, Twohy EL, Dixon JG, Giannini C, Jenkins R, Egorin MJ, Sarkaria JN, Brown PD, Flynn PJ, Schwerkoske J, Buckner JC, Galanis E.

J Neurooncol. 2019 Jul;143(3):583. doi: 10.1007/s11060-019-03201-3.

19.

Assembling the brain trust: the multidisciplinary imperative in neuro-oncology.

Ludmir EB, Mahajan A, Ahern V, Ajithkumar T, Alapetite C, Bernier-Chastagner V, Bindra RS, Bishop AJ, Bolle S, Brown PD, Carrie C, Chalmers AJ, Chang EL, Chung C, Dieckmann K, Esiashvili N, Gandola L, Ghia AJ, Gondi V, Grosshans DR, Harrabi SB, Horan G, Indelicato DJ, Jalali R, Janssens GO, Krause M, Laack NN, Laperriere N, Laprie A, Li J, Marcus KJ, McGovern SL, Merchant TE, Merrell KW, Padovani L, Parkes J, Paulino AC, Schwarz R, Shih HA, Souhami L, Sulman EP, Taylor RE, Thorp N, Timmermann B, Wheeler G, Wolden SL, Woodhouse KD, Yeboa DN, Yock TI, Kortmann RD, McAleer MF.

Nat Rev Clin Oncol. 2019 Aug;16(8):521-522. doi: 10.1038/s41571-019-0235-z. No abstract available.

PMID:
31150024
20.

Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).

Jaeckle KA, Anderson SK, Twohy EL, Dixon JG, Giannini C, Jenkins R, Egorin MJ, Sarkaria JN, Brown PD, Flynn PJ, Schwerkoske J, Buckner JC, Galanis E.

J Neurooncol. 2019 Jul;143(3):573-581. doi: 10.1007/s11060-019-03194-z. Epub 2019 May 22. Erratum in: J Neurooncol. 2019 Jun 5;:.

PMID:
31119479
21.

Dosimetric impact of esophagus motion in single fraction spine stereotactic body radiotherapy.

Wang X, Yang J, Zhao Z, Luo D, Court L, Zhang Y, Weksberg D, Brown PD, Li J, Ghia AJ.

Phys Med Biol. 2019 May 29;64(11):115010. doi: 10.1088/1361-6560/ab1c2b.

PMID:
31018191
22.

Breast cancer subtype and intracranial recurrence patterns after brain-directed radiation for brain metastases.

Cagney DN, Lamba N, Montoya S, Li P, Besse L, Martin AM, Brigell RH, Catalano PJ, Brown PD, Leone JP, Tanguturi SK, Haas-Kogan DA, Alexander BM, Lin NU, Aizer AA.

Breast Cancer Res Treat. 2019 Jul;176(1):171-179. doi: 10.1007/s10549-019-05236-6. Epub 2019 Apr 13.

PMID:
30982195
23.

Updates in the management of intradural spinal cord tumors: a radiation oncology focus.

Kotecha R, Mehta MP, Chang EL, Brown PD, Suh JH, Lo SS, Das S, Samawi HH, Keith J, Perry J, Sahgal A.

Neuro Oncol. 2019 Jun 10;21(6):707-718. doi: 10.1093/neuonc/noz014.

PMID:
30977511
24.

Risk of death, relapse or progression, and loss of life expectancy at different progression-free survival milestones in primary central nervous system lymphoma.

Biccler JL, Savage KJ, Brown PDN, Jørgensen J, Larsen TS, Poulsen CB, Stoltenberg D, Sehn LH, Scott DW, Gerrie AS, Jakobsen LH, Bøgsted M, El-Galaly TC, Villa D.

Leuk Lymphoma. 2019 Oct;60(10):2516-2523. doi: 10.1080/10428194.2019.1594219. Epub 2019 Apr 3.

PMID:
30943052
25.

Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?

Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu J, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, Cameron B, Attia A, Molitoris J, Wu CC, Wang TJC, Lockney N, Beal K, Parkhurst J, Buatti JM, Shanley R, Lou E, Tandberg DD, Kirkpatrick JP, Shi D, Shih HA, Chuong M, Saito H, Aoyama H, Masucci L, Roberge D, Mehta MP.

Transl Res. 2019 Jun;208:63-72. doi: 10.1016/j.trsl.2019.02.011. Epub 2019 Feb 27.

PMID:
30885538
26.

A Multi-Institutional Analysis of Presentation and Outcomes for Leptomeningeal Disease Recurrence After Surgical Resection and Radiosurgery for Brain Metastases.

Prabhu RS, Turner BE, Asher AL, Marcrom SR, Fiveash JB, Foreman PM, Press RH, Patel KR, Curran WJ, Breen WG, Brown PD, Jethwa KR, Grills IS, Arden JD, Foster LM, Manning MA, Stern JD, Soltys SG, Burri SH.

Neuro Oncol. 2019 Mar 4. pii: noz049. doi: 10.1093/neuonc/noz049. [Epub ahead of print]

PMID:
30828727
27.

Recent Developments and Future Directions in Adult Lower-Grade Gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) Consensus.

Schiff D, van den Bent M, Vogelbaum MA, Wick W, Miller CR, Taphoorn M, Pope W, Brown PD, Platten M, Jalali R, Armstrong T, Wen PY.

Neuro Oncol. 2019 Feb 8. doi: 10.1093/neuonc/noz033. [Epub ahead of print]

PMID:
30753579
28.

Local control after brain-directed radiation in patients with cystic versus solid brain metastases.

Brigell RH, Cagney DN, Martin AM, Besse LA, Catalano PJ, Lee EQ, Wen PY, Brown PD, Phillips JG, Pashtan IM, Tanguturi SK, Haas-Kogan DA, Alexander BM, Aizer AA.

J Neurooncol. 2019 Apr;142(2):355-363. doi: 10.1007/s11060-019-03106-1. Epub 2019 Feb 4.

PMID:
30715665
29.

Factors Associated With Meningioma Detected in a Population-Based Sample.

Cerhan JH, Butts AM, Syrjanen JA, Aakre JA, Brown PD, Petersen RC, Jack CR Jr, Roberts RO.

Mayo Clin Proc. 2019 Feb;94(2):254-261. doi: 10.1016/j.mayocp.2018.07.026.

PMID:
30711123
30.

Stereotactic Spinal Radiosurgery and Delayed Vertebral Fracture Risk.

Evans JD, Brown PD, Olivier KR.

Adv Radiat Oncol. 2018 Sep 19;4(1):20-25. doi: 10.1016/j.adro.2018.09.005. eCollection 2019 Jan-Mar. No abstract available.

31.

The impact of histopathology and NAB2-STAT6 fusion subtype in classification and grading of meningeal solitary fibrous tumor/hemangiopericytoma.

Fritchie K, Jensch K, Moskalev EA, Caron A, Jenkins S, Link M, Brown PD, Rodriguez FJ, Guajardo A, Brat D, Velázquez Vega JE, Perry A, Wu A, Raleigh DR, Santagata S, Louis DN, Brastianos PK, Kaplan A, Alexander BM, Rossi S, Ferrarese F, Haller F, Giannini C.

Acta Neuropathol. 2019 Feb;137(2):307-319. doi: 10.1007/s00401-018-1952-6. Epub 2018 Dec 24.

32.

Preoperative Stereotactic Radiosurgery for Brain Metastases.

Routman DM, Yan E, Vora S, Peterson J, Mahajan A, Chaichana KL, Laack N, Brown PD, Parney IF, Burns TC, Trifiletti DM.

Front Neurol. 2018 Nov 13;9:959. doi: 10.3389/fneur.2018.00959. eCollection 2018. Review.

33.

Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool.

Sperduto PW, Deegan BJ, Li J, Jethwa KR, Brown PD, Lockney N, Beal K, Rana NG, Attia A, Tseng CL, Sahgal A, Shanley R, Sperduto WA, Lou E, Zahra A, Buatti JM, Yu JB, Chiang V, Molitoris JK, Masucci L, Roberge D, Shi DD, Shih HA, Olson A, Kirkpatrick JP, Braunstein S, Sneed P, Mehta MP.

Neuro Oncol. 2018 Nov 12;20(12):1652-1660. doi: 10.1093/neuonc/noy099.

34.

Single versus Multifraction Stereotactic Radiosurgery for Large Brain Metastases: An International Meta-analysis of 24 Trials.

Lehrer EJ, Peterson JL, Zaorsky NG, Brown PD, Sahgal A, Chiang VL, Chao ST, Sheehan JP, Trifiletti DM.

Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):618-630. doi: 10.1016/j.ijrobp.2018.10.038. Epub 2018 Nov 2.

PMID:
30395902
35.

The Future Is Now-Prospective Study of Radiosurgery for More Than 4 Brain Metastases to Start in 2018!

Roberge D, Brown PD, Whitton A, O'Callaghan C, Leis A, Greenspoon J, Smith GL, Hu JJ, Nichol A, Winch C, Chan MD.

Front Oncol. 2018 Sep 13;8:380. doi: 10.3389/fonc.2018.00380. eCollection 2018.

36.

Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: An international meta-analysis of individual patient data.

Lehrer EJ, Peterson J, Brown PD, Sheehan JP, Quiñones-Hinojosa A, Zaorsky NG, Trifiletti DM.

Radiother Oncol. 2019 Jan;130:104-112. doi: 10.1016/j.radonc.2018.08.025. Epub 2018 Sep 18. Review.

PMID:
30241791
37.

Postoperative Cavity Stereotactic Radiosurgery for Brain Metastases.

Marchan EM, Peterson J, Sio TT, Chaichana KL, Harrell AC, Ruiz-Garcia H, Mahajan A, Brown PD, Trifiletti DM.

Front Oncol. 2018 Aug 31;8:342. doi: 10.3389/fonc.2018.00342. eCollection 2018. Review.

38.

Irrational fear of whole-brain radiotherapy: Are we doing our patients a disservice?

Brown PD, Gondi V.

Cancer. 2018 Sep 1;124(17):3468-3473. doi: 10.1002/cncr.31649. Epub 2018 Sep 7. No abstract available.

39.

Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation.

Kruser TJ, Gondi V, Sperduto PW, Brown PD, Mehta MP.

Lancet Oncol. 2018 Aug;19(8):e366. doi: 10.1016/S1470-2045(18)30439-X. No abstract available.

PMID:
30102216
40.

Phase 1 Study of Spinal Cord Constraint Relaxation With Single Session Spine Stereotactic Radiosurgery in the Primary Management of Patients With Inoperable, Previously Unirradiated Metastatic Epidural Spinal Cord Compression.

Ghia AJ, Guha-Thakurta N, Hess K, Yang JN, Settle SH, Sharpe HJ, Li J, McAleer M, Chang EL, Tatsui CE, Brown PD, Rhines LD.

Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1481-1488. doi: 10.1016/j.ijrobp.2018.07.2023. Epub 2018 Aug 9.

PMID:
30099131
41.

Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery.

Chung C, Bryant A, Brown PD.

Cochrane Database Syst Rev. 2018 Jul 9;7:CD011492. doi: 10.1002/14651858.CD011492.pub2. Review.

42.

Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases.

Sperduto PW, Deegan BJ, Li J, Jethwa KR, Brown PD, Lockney N, Beal K, Rana NG, Attia A, Tseng CL, Sahgal A, Shanley R, Sperduto WA, Lou E, Zahra A, Buatti JM, Yu JB, Chiang V, Molitoris JK, Masucci L, Roberge D, Shi DD, Shih HA, Olson A, Kirkpatrick JP, Braunstein S, Sneed P, Mehta MP.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):845-853. doi: 10.1016/j.ijrobp.2018.04.006. Epub 2018 Apr 12.

PMID:
29976497
43.

Chemotherapy Plus Proton or Photon Radiation on a Trial.

Grosshans DR, Brown PD.

Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):518-519. doi: 10.1016/j.ijrobp.2018.02.171. No abstract available.

PMID:
29893270
44.

Implications of Screening for Brain Metastases in Patients With Breast Cancer and Non-Small Cell Lung Cancer.

Cagney DN, Martin AM, Catalano PJ, Brown PD, Alexander BM, Lin NU, Aizer AA.

JAMA Oncol. 2018 Jul 1;4(7):1001-1003. doi: 10.1001/jamaoncol.2018.0813. No abstract available.

45.

Preoperative Vs Postoperative Radiosurgery For Resected Brain Metastases: A Review.

Prabhu RS, Patel KR, Press RH, Soltys SG, Brown PD, Mehta MP, Asher AL, Burri SH.

Neurosurgery. 2019 Jan 1;84(1):19-29. doi: 10.1093/neuros/nyy146.

PMID:
29771381
46.

Tissue Distribution of Kir7.1 Inwardly Rectifying K+ Channel Probed in a Knock-in Mouse Expressing a Haemagglutinin-Tagged Protein.

Cornejo I, Villanueva S, Burgos J, López-Cayuqueo KI, Chambrey R, Julio-Kalajzić F, Buelvas N, Niemeyer MI, Figueiras-Fierro D, Brown PD, Sepúlveda FV, Cid LP.

Front Physiol. 2018 Apr 23;9:428. doi: 10.3389/fphys.2018.00428. eCollection 2018.

47.

Protons vs Photons for Brain and Skull Base Tumors.

Ahmed SK, Brown PD, Foote RL.

Semin Radiat Oncol. 2018 Apr;28(2):97-107. doi: 10.1016/j.semradonc.2017.11.001. Review.

PMID:
29735196
48.

Stereotactic radiosurgery for trigeminal pain secondary to recurrent malignant skull base tumors.

Phan J, Pollard C, Brown PD, Guha-Thakurta N, Garden AS, Rosenthal DI, Fuller CD, Frank SJ, Gunn GB, Morrison WH, Ho JC, Li J, Ghia AJ, Yang JN, Luo D, Wang HC, Su SY, Raza SM, Gidley PW, Hanna EY, DeMonte F.

J Neurosurg. 2018 Apr 27;130(3):812-821. doi: 10.3171/2017.11.JNS172084.

PMID:
29701557
49.

Hypopituitarism After Single-Fraction Pituitary Adenoma Radiosurgery: Dosimetric Analysis Based on Patients Treated Using Contemporary Techniques.

Graffeo CS, Link MJ, Brown PD, Young WF Jr, Pollock BE.

Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):618-623. doi: 10.1016/j.ijrobp.2018.02.169. Epub 2018 Mar 8.

PMID:
29678524
50.

Total synthesis of incargranine A.

Brown PD, Lawrence AL.

Org Biomol Chem. 2019 Feb 13;17(7):1698-1702. doi: 10.1039/c8ob00702k.

PMID:
29638233

Supplemental Content

Loading ...
Support Center